{
    "body": "Where are the orexigenic peptides synthesized?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22771813", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25258168", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23707377", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25047666", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24991043", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22325091", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25502749", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21903140", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22922128", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25039297", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21574955", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25241055", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25017744"
    ], 
    "ideal_answer": [
        "The orexigenic peptides are sythesized in the hypothalamus."
    ], 
    "exact_answer": [
        "The orexigenic peptides are sythesized in the hypothalamus."
    ], 
    "type": "factoid", 
    "id": "56e47e0051531f7e3300001c", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 84, 
            "text": "Orexin A and B, orexigenic peptides produced primarily by the lateral hypothalamus t", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25502749", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1409, 
            "offsetInEndSection": 1528, 
            "text": "Telmisartin reduced hypothalamic mRNA levels of the orexigenic peptides melanin-concentrating hormone and prepro-orexin", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25258168", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1517, 
            "offsetInEndSection": 1636, 
            "text": "expression of the orexigenic peptides, enkephalin (ENK) and galanin (GAL), in developing embryonic hypothalamic neurons", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25039297", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1503, 
            "offsetInEndSection": 1536, 
            "text": "hypothalamic orexigenic peptides,", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24991043", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 264, 
            "offsetInEndSection": 418, 
            "text": " Such mechanisms may involve orexigenic peptides known to stimulate alcohol intake through their actions in the hypothalamic paraventricular nucleus (PVN)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25241055", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1264, 
            "offsetInEndSection": 1296, 
            "text": "hypothalamus orexigenic peptides", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25017744", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 518, 
            "offsetInEndSection": 585, 
            "text": " the hypothalamic mRNA expression of endogenous orexigenic peptides", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25047666", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 239, 
            "offsetInEndSection": 329, 
            "text": "The hypothalamus integrates peripheral and central signals to generate satiety or hunger. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23707377", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 950, 
            "offsetInEndSection": 1054, 
            "text": "increase in mRNA expression of hypothalamic orexigenic peptides and a decrease of anorexigenic peptides;", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22771813", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 605, 
            "offsetInEndSection": 772, 
            "text": "expression of the orexigenic peptides, galanin (GAL) in the hypothalamic paraventricular nucleus (PVN) and orexin (OX) in the perifornical lateral hypothalamus (PFLH).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21903140", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 642, 
            "offsetInEndSection": 883, 
            "text": "Expression of orexigenic peptides neuropeptide Y (NPY) and agouti-related protein (AgRP) decreased in the hypothalamus of metformin-treated diabetic rats, though anorexigenic peptides pro-opiomelanocortin (POMC) did not change significantly.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22325091", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 38, 
            "offsetInEndSection": 71, 
            "text": "hypothalamic orexigenic peptides ", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22922128", 
            "endSection": "title"
        }
    ]
}